Supreme Group, a next-generation agency platform purpose-built for healthcare and life sciences marketing and communications, announced it has acquired Pivot Design, a globally recognized agency known for infusing health brands with humanity and bold storytelling. This latest milestone marks Supreme Group's ninth acquisition in just 18 months, reflecting the company's momentum and continued investment in building an unmatched collective of talent and capabilities to deliver client impact.
With Pivot Design, Supreme Group significantly expands its leadership in pharma and rare disease, gaining a team celebrated for translating complex science into breakthrough brand experience. Pivot's legacy spans three decades of helping healthcare innovators connect with patients and professionals through strategy, creative excellence and omnichannel campaigns that drive real-world change.
Pivot Design's reputation for breaking through complexity with empathy and creativity has made it a trusted partner across the healthcare spectrum, and recently earned the agency a finalist spot in MM+M's Rare Disease Agency of the Year and Best Use of Market Access Marketing.
"We weren't looking for just any partner, we were looking for the right one," said Liz Kanter, president of Pivot Design. "Supreme Group shares our values and respects our independence, while providing us with powerful tools in AI, technology and data to help us scale our impact. This acquisition allows us to stay true to who we are, bringing soul to our clients and communities, while evolving within a rapidly changing healthcare landscape."
Pivot Design will maintain its brand identity and leadership structure, while gaining access to enhanced capabilities and inter-agency collaboration through the connected Supreme Group platform.
"Pivot stands out for its ability to bring clarity and emotional brand connections to some of the most challenging areas in healthcare," said Tom Donnelly, CEO of Supreme Group. "By welcoming Pivot to Supreme Group, we're deepening our expertise in rare disease and pharma, and expanding the creative and omnichannel solutions we deliver for our clients. This is about helping healthcare brands break through barriers, move faster, and lead with measurable impact, no matter how complex the challenge."
Comments powered by CComment